Projects per year
Personal profile
Biography
Jenny Lee is a medical oncologist who is part of the Precision Cancer Therapy Laboratory as the clinical lead. Her research interests include melanoma and lung cancer, especially in understanding the mechanisms behind immunotherapy response and resistance, and biomarker discovery.
Fingerprint
- 6 Similar Profiles
Collaborations and top research areas from the last five years
-
A Prelude towards transforming adenoid cystic carcinoma into an immune hot tumour
Chakraborty, R., Packer, N., Shannon, K., Rizos, H., Lee, J., Nasiri, N., Dawes, J., Tay, A. & Surya, V.
1/01/25 → 30/06/26
Project: Research
-
The ACRF Centre for Advanced Cancer Modelling and Experimental Oncology (COMET)
Rizos, H., Gurney, H., Shklovskaya, E., Long, G. V., Lee, J., Wang, Y., Di Ieva, A., Guller, A., Clarke AM, J. & Gupta, R.
1/01/24 → 31/12/30
Project: Research
-
USYD Led: Reducing the Morbidity of Head and Neck Cancer Treatment
Clark, J., Gupta, R., Lee, J., Ashford, B. G., Ranson, M., Boyer, M., Rizos, H., Yang, J. Y. H., Suaning, G. J. & Wallace, G. G.
1/02/21 → 31/01/26
Project: Research
-
To investigate the role of circulating tumour DNA in early and advanced melanoma.
9/06/16 → 9/06/17
Project: Research
-
Circulating tumour DNA dynamics predict recurrence in stage III melanoma patients receiving neoadjuvant immunotherapy
Chan, W. Y., Lee, J. H., Stewart, A., Diefenbach, R. J., Gonzalez, M., Menzies, A. M., Blank, C., Scolyer, R. A., Long, G. V. & Rizos, H., 21 Aug 2024, In: Journal of Experimental and Clinical Cancer Research. 43, 1, p. 1-9 9 p., 238.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Citations (Scopus)25 Downloads (Pure) -
Ex vivo tissue modelling informs drug selection for rare cancers
Lee, J. H., Ming, Z., Cheung, V. K. Y., Pedersen, B., Wykes, J. J., Palme, C. E., Clark, J. J., Gupta, R. & Rizos, H., 1 Apr 2024, In: International Journal of Cancer. 154, 7, p. 1158-1163 6 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile69 Downloads (Pure) -
Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
Menzies, A. M., Lo, S. N., Saw, R. P. M., Gonzalez, M., Ch'ng, S., Nieweg, O. E., Shannon, K. F., Ferguson, P. M., Lee, J., Emmett, L., Kapoor, R., Rawson, R. V., Stretch, J. R., Thompson, J. F., Spillane, A. J., Rizos, H., Scolyer, R. A. & Long, G. V., Aug 2024, In: Annals of Oncology. 35, 8, p. 739-746 8 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Immune checkpoint inhibitor therapy for advanced cutaneous squamous cell carcinoma in Australia: a retrospective real world cohort study
McLean, L. S., Lim, A. M., Bressel, M., Lee, J., Ladwa, R., Guminski, A. D., Hughes, B., Bowyer, S., Briscoe, K., Harris, S., Kukard, C., Zielinski, R., Alamgeer, M., Carlino, M., Mo, J., Park, J. J., Khattak, M. A., Day, F. & Rischin, D., 5 Feb 2024, In: Medical Journal of Australia. 220, 2, p. 80-90 11 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile7 Citations (Scopus)66 Downloads (Pure) -
Single-cell RNA sequencing reveals melanoma cell state-dependent heterogeneity of response to MAPK inhibitors
Lim, S. Y., Lin, Y., Lee, J. H., Pedersen, B., Stewart, A., Scolyer, R. A., Long, G. V., Yang, J. Y. H. & Rizos, H., Sept 2024, In: EBioMedicine. 107, p. 1-14 14 p., 105308.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)21 Downloads (Pure)